September 22, 2021

HRSA Notifies Six Drug Manufacturers of Referral to OIG for Possible Penalties

The Health Resources and Services Administration (HRSA) has taken additional steps to require 340B drug discounts when drugs are dispensed through contract pharmacies. On September 22, HRSA followed up on earlier letters to six manufacturers refusing contract pharmacy discounts, notifying them in an updated letter that HRSA has referred the issue to the Office of Inspector General (OIG) for the possible assessment of civil monetary penalties.